稳定性弥漫性胶质瘤患者具有可重复的神经认知特征:数据驱动方法解析认知异质性
研究对稳定性弥漫性胶质瘤患者(治疗后≥2个月无临床或影像学进展)进行五个认知域评估,采用层次聚类分析识别神经认知特征并在独立队列中验证。研究队列(N=108)和验证队列(N=185)均识别出四种可重复的神经认知特征:保留型、记忆型、加工/注意型和多域型;两队列中40%患者存在神经认知功能受损。肿瘤半球和既往放疗或放化疗与加工/注意型及多域型特征相关。
要点
- 稳定性胶质瘤患者中40%存在神经认知功能受损,44%研究队列和38%验证队列至少一个认知域缺陷。
- 神经认知功能可分类为四种可重复特征:保留型、记忆型、加工/注意型和多域型。
- 肿瘤半球及既往放疗或放化疗与加工/注意型和多域型特征相关。
核心结论
- 胶质瘤患者的神经认知功能可分类为四种可重复的特征,且并发认知问题高度普遍。
- 神经认知特征与肿瘤侧别、既往肿瘤治疗及自评认知功能相关,但与其他临床特征无关。
研究设计与样本
- 研究纳入稳定性弥漫性胶质瘤患者(治疗后≥2个月无临床或影像学进展),评估注意力、信息加工速度、言语记忆、工作记忆和灵活性五个认知域。
- 采用层次聚类分析区分神经认知特征,并在独立胶质瘤队列中重复验证这些特征。
- 使用多项逻辑回归分析神经认知特征与临床特征之间的关联。
主要发现
- 研究队列(N=108)和验证队列(N=185)均识别出四种神经认知特征:保留型、记忆型、加工/注意型和多域型。
- 两队列中40%患者存在神经认知功能受损;至少一个认知域缺陷在研究队列为44%,验证队列为38%。
- 研究队列中,肿瘤半球和既往放疗或联合放化疗与加工/注意型和多域型特征相关。
- 两队列中,多域型特征与自评神经认知功能呈弱关联。
- 未观察到神经认知特征与患者、肿瘤或治疗特征的其他显著关联。
临床怎么用
- 对稳定性胶质瘤患者应关注神经认知功能的多域评估,识别不同认知特征以指导个体化管理。
- 肿瘤侧别及既往放疗或放化疗史可提示特定认知特征风险,需在随访中加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma patients often exhibit neurocognitive deficits across multiple domains, yet studies typically assess these impairments separately. This study explores aggregated neurocognitive functioning (NCF), identifying distinct profiles and their clinical correlates. METHODS: NCF in glioma patients with stable disease (≥ 2 months after treatment without clinical or radiological progression) was assessed across five domains: attention, information processing speed, verbal memory, working memory, and flexibility. We used hierarchical cluster analysis to distinguish neurocognitive profiles and replicated these profiles in an independent glioma cohort. Associations between neurocognitive profiles and clinical characteristics were examined using multinomial logistic regression. RESULTS: Four distinct neurocognitive profiles were identified in both the study (N = 108) and the validation cohort (N = 185): a preserved, memory, processing/attention, and multi-domain profile. In both cohorts, 40% of patients exhibited impaired NCF, with deficits in at least one domain observed in 44% in the study cohort and 38% in the validation cohort. In the study cohort, tumor hemisphere and prior treatment with radiotherapy or combined radio- and chemotherapy were associated with processing/attention and multi-domain profiles. In both the cohorts, the multi-domain profile showed a weak association with self-perceived NCF. No other significant associations with patient, tumor, or treatment characteristics were observed. CONCLUSIONS: NCF in glioma patients can be classified into four reproducible neurocognitive profiles. Importantly, concurrent problems in NCF are highly prevalent. Neurocognitive profiles are associated with tumor laterality, previous oncological treatment, and self-perceived NCF, but not with other clinical characteristics.
引用
- Gorter M, Röttgering JG, Belgers V, et al. Distinct and reproducible neurocognitive profiles in stable diffuse glioma: A data-driven approach to understanding cognitive heterogeneity. Neuro Oncol. 2025. PMID: 40878319. doi:10.1093/neuonc/noaf197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。